MOTS-c
A peptide your mitochondria naturally make. In animal studies, it mimics the metabolic benefits of exercise — improving how your body burns fat and handles blood sugar. No human trials exist yet.
MOTS-c is a mitochondrial peptide that activates your body's master metabolic switch (AMPK). In mice, it improves insulin sensitivity, burns fat, and acts like exercise — even without any actual exercise. It's one of the most interesting longevity peptides, but all evidence is preclinical.
Who's interested: People in the longevity and biohacking space looking at metabolic optimization — particularly those with insulin resistance, metabolic syndrome, or age-related metabolic decline.
Dive deeper into the researchPotential side effects
- Injection site reactions (redness, swelling)
- Possible blood sugar fluctuations due to AMPK activation
- Unknown long-term safety — no human data exists
What does MOTS-c do?
Your mitochondria — the tiny power plants inside every cell — don't just make energy. They also produce signaling peptides that talk to the rest of your body. MOTS-c is one of those peptides.
When MOTS-c is released, it activates AMPK — a protein that acts like your body's metabolic thermostat. AMPK tells your cells to burn more fat, take up more glucose, and clean out damaged components (autophagy). It's the same pathway activated by exercise, fasting, and metformin.
In mouse studies, injecting MOTS-c into sedentary animals produced metabolic improvements similar to regular exercise — better insulin sensitivity, less body fat, improved endurance. That's what makes it so interesting to longevity researchers.
Who uses it?
MOTS-c is used almost exclusively in the biohacking and longevity research community. You'll see it discussed by people who are:
- Interested in metabolic optimization and insulin sensitivity
- Looking for exercise-mimetic compounds (not as a replacement, but as a complement)
- Dealing with age-related metabolic decline
- Already deep in the peptide space and comfortable with experimental compounds
This is not a beginner peptide. If you're new to peptides, start with something that has more human data behind it.
What to know before trying
MOTS-c has zero human clinical trials. Everything we know comes from mice and cell studies. Using it means you're experimenting on yourself with a compound that hasn't been tested for safety or efficacy in people.
- Source quality matters enormously — MOTS-c from peptide vendors varies widely. Always request a Certificate of Analysis with HPLC purity testing (≥98%)
- It requires injection — reconstitute lyophilized powder with bacteriostatic water, inject subcutaneously
- Dosing is extrapolated — the 5–10 mg, 2–3x/week protocol comes from scaling mouse data, not human studies
- Natural levels decline with age — your body makes less MOTS-c as you get older, which is part of the rationale for supplementation
- Not approved anywhere — MOTS-c is not approved as a drug or supplement in any country
Tracking a peptide protocol?
eterni connects your labs, supplements, and retests — so you can see whether your protocol is actually working.
Get early accessFrequently Asked Questions
What is MOTS-c and why do people use it?
MOTS-c is a 16-amino acid peptide made by your mitochondria. It activates AMPK — a key metabolic switch — which improves how your body burns fat and handles blood sugar. In animal studies, it mimics many benefits of exercise. People in the longevity space use it hoping to improve metabolic health, but there are no human trials yet.
Is MOTS-c an exercise replacement?
In mice, MOTS-c injections improved insulin sensitivity and reduced body fat similar to regular exercise. But these are animal studies only. No human trial has confirmed this effect. Even if it works in humans, it would likely complement exercise, not replace it.
Is MOTS-c legal in India?
MOTS-c is not approved as a drug or supplement in India. It is sold as a research chemical through peptide vendors. It is not a scheduled substance but exists in a regulatory grey area — not illegal to possess, but not approved for human use.
Are there any human studies on MOTS-c?
No. As of 2026, all MOTS-c research is from cell culture and animal models. Observational studies show that MOTS-c levels decline with age and are lower in people with metabolic syndrome, but no clinical trial has tested MOTS-c supplementation in humans.
How it works in your body
MOTS-c is encoded in your mitochondrial DNA — not your nuclear DNA where most proteins come from. It's part of a class called mitochondria-derived peptides (MDPs), which also includes Humanin.
When released, MOTS-c inhibits an enzyme called ATIC in the folate cycle. This causes a buildup of AICAR — a natural AMPK activator. The result is a cascade of metabolic improvements: more fat burning, better glucose uptake, and increased autophagy.
Under metabolic stress, MOTS-c can even travel from your mitochondria into your cell nucleus, where it acts as a transcription factor — directly switching on stress-response genes. This is unusual for a mitochondrial peptide and suggests a much deeper regulatory role.
Animal vs human evidence
- Mouse studies: Sedentary mice given MOTS-c showed improved insulin sensitivity, reduced body fat, and better endurance — comparable to exercised mice
- Aging mice: Older mice treated with MOTS-c maintained more youthful metabolic profiles
- Human observational: People with type 2 diabetes and metabolic syndrome have lower circulating MOTS-c levels than healthy controls
- Human trials: None. Zero published intervention studies in humans
MOTS-c vs SLU-PP-332
Both are called "exercise mimetics" but work through completely different pathways:
| MOTS-c | SLU-PP-332 | |
|---|---|---|
| Type | Endogenous peptide (your body makes it) | Synthetic small molecule |
| Mechanism | AMPK activation via folate cycle | ERR agonism (transcription factors) |
| Human data | None | None |
| Route | Injection | Oral (in animal studies) |
Side effects & safety
Because no human trials exist, the side effect profile of MOTS-c in humans is genuinely unknown. What we can say:
- Injection site reactions — redness, swelling, and mild pain at the injection site are reported anecdotally
- Blood sugar changes — AMPK activation can lower blood sugar. If you're on diabetes medication, this could cause hypoglycemia
- Unknown long-term risks — no data on what happens with months or years of use
- Immune modulation — some evidence suggests MOTS-c affects immune cell function; implications unclear
- Quality concerns — the biggest practical risk is contaminated or mislabeled product from unreliable vendors
Who should avoid it: Anyone on diabetes medication (risk of hypoglycemia), pregnant or breastfeeding women, people with active cancer, and anyone not comfortable with the reality that this compound has no human safety data.
Which labs to monitor
If you're using MOTS-c, track these before starting and every 8–12 weeks:
- Fasting glucose & HbA1c — primary metabolic targets
- Fasting insulin & HOMA-IR — insulin sensitivity markers
- Lipid panel — AMPK activation affects lipid metabolism
- Liver enzymes (ALT, AST) — baseline safety monitoring
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist